Veru (VERU) Other Operating Expenses (2012 - 2026)
Veru (VERU) posted quarterly Other Operating Expenses of $351418.0 for Q1 2026, up 982.6% year-over-year from $32460.4 in Q1 2025, and up 134.92% quarter-over-quarter from $149588.0 in Q3 2025.
Veru (VERU) Other Operating Expenses (2012 - 2026) Analysis & Trends
Veru (VERU) has reported Other Operating Expenses for 13 consecutive years, with $351418.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses rose 982.6% year-over-year to $351418.0; the TTM figure through Mar 2026 stood at $491852.0 (up 7.92% YoY), while the FY2025 annual figure was -$4.1 million, changed N/A from the prior year.
- Other Operating Expenses grew to $351418.0 in Q1 2026 per VERU's latest filing, from $149588.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $7.8 million in Q1 2023 and bottomed at -$4.2 million in Q4 2024.
- Historically, Other Operating Expenses has averaged $1.2 million across 5 years, with a median of -$2000.0 in 2022.
- Annual changes were most pronounced in 2023 — Other Operating Expenses soared 390685.7% — and 2025, when it sank 96.82%.
- Veru's Other Operating Expenses stood at -$2000.0 in 2022, then soared by 236281.15% to $4.7 million in 2023, then plunged by 189.01% to -$4.2 million in 2024, then soared by 103.56% to $149588.0 in 2025, then soared by 134.92% to $351418.0 in 2026.
- Business Quant data shows VERU's Other Operating Expenses at $351418.0 in Q1 2026, $149588.0 in Q3 2025, and -$9154.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 351,418.00 |
| Sep 30, 2025 | 149,588.00 |
| Jun 30, 2025 | -9,154.00 |
| Mar 31, 2025 | -39,816.00 |
| Dec 31, 2024 | -4.20 Mn |
| Sep 30, 2024 | 4.70 Mn |
| Jun 30, 2023 | 4.72 Mn |
| Mar 31, 2023 | 7.81 Mn |
| Sep 30, 2022 | -2,000.00 |
| Jun 30, 2022 | -2,500.00 |
| Mar 31, 2022 | -2,000.00 |
| Dec 31, 2020 | 18.41 Mn |
| Jun 30, 2018 | 227,208.00 |
| Dec 31, 2017 | 3.76 Mn |
| Sep 30, 2016 | 1.57 Mn |
| Dec 31, 2015 | 3.01 Mn |
| Sep 30, 2015 | 3.36 Mn |
| Jun 30, 2015 | 3.18 Mn |
| Mar 31, 2015 | 3.44 Mn |
| Dec 31, 2014 | 2.37 Mn |